Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-669899f699-ggqkh Total loading time: 0 Render date: 2025-05-05T07:50:02.584Z Has data issue: false hasContentIssue false

55 - Treatment of depressive disorders in children and adolescents

from Part III - Specific treatments

Published online by Cambridge University Press:  12 May 2010

By
Kelly Schloredt ,
Rachel Gershenson ,
Christopher K. Varley ,
Paul Wilkinson  and
Ian Goodyer
Edited by
Peter Tyrer  and
Kenneth R. Silk
Kelly Schloredt
Affiliation:
Childrens' Hospital and Regional Medical Centre Seattle, WA USA
Rachel Gershenson
Affiliation:
DePaul University Chicago, IL USA
Christopher K. Varley
Affiliation:
Department of Child and Adolescent Psychiatry University of Washington School of Medicine Seattle, WA USA
Paul Wilkinson
Affiliation:
Section of Developmental Psychiatry Cambridge UK
Ian Goodyer
Affiliation:
Cambridge University Douglas House Cambridge UK
Peter Tyrer
Affiliation:
Imperial College of Science, Technology and Medicine, London
Kenneth R. Silk
Affiliation:
University of Michigan, Ann Arbor
Get access

Summary

Editor's note

The treatment of depression in children and adolescents has commanded much attention in the news in both the USA and the UK. In the UK, there are very strong guidelines against the use of any SSRI antidepressants except fluoxetine, and the guidelines urge that, if fluoxetine is used, it should be used only in moderate to severe cases and should always be accompanied by some psychotherapeutic efforts. In the USA, the advice is somewhat less strict in that SSRIs other than fluoxetine are not advised against, but there is a ‘block box’ issued that reminds clinicians to weigh the costs vs. the benefits of SSRI usage. One of the costs of using SSRIs may be an increase in suicidal ideation if not actual suicide among users of these medications, though the evidence here is not as strong as critics of SSRI usage would like it to be. Psychotherapeutic treatments, especially cognitive-behavioural treatment (CBT) and interpersonal therapy (IPT) have been shown to be effective interventions for depression in youth. Yet there are also questions not to its effectiveness per se, but as to the duration of the effectiveness. The current thinking in the treatment of depression in both children and adolescents suggests that in milder depression one should try non-pharmacologic treatments at first, and if they do not prove to be effective, then pharmacologic treatment can be added.

Type
Chapter
Information
Cambridge Textbook of Effective Treatments in Psychiatry , pp. 808 - 818
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

American Academy of Child and Adolescent Psychiatry (2004). Practice parameter for use of electroconvulsive therapy with adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 43(12), 1521–39.CrossRef
American College of Neuropsychopharmacology (2004). Executive Summary: Preliminary report of the Task Force on SSRIs and suicidal behavior in youth. http://www.acnp.org/exec_summary.pdf.
Asarnow, J. R., Scott, C. V. & Mintz, J. (2002). A combined cognitive-behavioral family education intervention for depression in children: a treatment development study. Cognitive Therapy & Research, 26(2), 221–9.CrossRefGoogle Scholar
Baer, J. S., MacLean, M. G. & Marlatt, G. A. (1998). Linking etiology and treatment for adolescent substance abuse: toward a better match. In New Perspectives on Adolescent Risk Behavior, ed. Jessor, R., pp. 182–211. New York: Cambridge University Press.CrossRefGoogle Scholar
Bemporad, J. R. (1988). Psychodynamic treatment of depressed adolescents. Journal of Clinical Psychiatry, 49 (Suppl). 26–31.Google ScholarPubMed
Birmaher, B., Ryan, N. D., Brent, D., Dahl, R. E., Kaufman, J. & Williamson, D. E. (1996a). Child and adolescent depression: a review of the past ten years. Part I. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1427–39.CrossRefGoogle Scholar
Birmaher, B., Ryan, N. D., Williamson, D. E., Brent, D. A. & Kaufman, J. (1996b). Childhood and adolescent depression: a review of the past 10 years. Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1575–83.CrossRefGoogle Scholar
Birmaher, B., Brent, D. A. & Benson, R. S. (1998). Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of American Academy of Child and Adolescent Psychiatry, 37, 1234–8.CrossRefGoogle ScholarPubMed
Birmaher, B., Brent, D. A., Kolko, D.et al. (2000). Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Archives of General Psychiatry, 57, 29–36.CrossRefGoogle ScholarPubMed
Brent, D. A., Holder, D., Kolko, D.et al. (1997). A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry, 54, 877–85.CrossRefGoogle ScholarPubMed
Brent, D. A., Kolko, D., Birmaher, B., Baugher, M., Bridge, J., Roth, C. & Holder, D. (1998). Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. Journal of American Academy of Child and Adolescent Psychiatry, 37, 906–14.CrossRefGoogle Scholar
Brent, D. A. & Birmaher, B. (2004). British warnings on SSRI's questioned. Journal of the American Academy of Child and Adolescent Psychiatry, 43(4), 379–80.CrossRefGoogle Scholar
Clarke, G. N., Rohde, P., Lewinsohn, P. M., Hops, H. & Seeley, J. R. (1999). Cognitive-behavioral treatment of adolescent depression: Efficacy of acute group treatment and booster sessions. Journal of American Academy of Child and Adolescent Psychiatry, 38, 272–9.CrossRefGoogle ScholarPubMed
Clarke, G., Debar, L., Lynch, F.et al. (2005). A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 888–98.CrossRefGoogle ScholarPubMed
Cohen, D., Taieb, O., Flament, M.et al. (2000). Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. American Journal of Psychiatry, 157, 460–2.CrossRefGoogle ScholarPubMed
Cottrell, D. (2003). Outcome studies of family therapy in child and adolescent depression. Journal of Family Therapy, 25(4), 406–16.CrossRefGoogle Scholar
Curry, J. F. (2001). Specific psychotherapies for childhood and adolescent depression. Biological Psychiatry, 49(12), 1091–100.CrossRefGoogle ScholarPubMed
Daviss, W. B., Bentivoglio, P., Racusin, R., Brown, K. M., Bostic, J. Q. & Wiley, L. (2001). Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 307–14.CrossRefGoogle ScholarPubMed
Delate, T., Gelenberg, A. J., Simmons, V. A. & Motheral, B. R. (2004). Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatric Services, 55(4), 387–91.CrossRefGoogle Scholar
Diamond, G. & Siqueland, L. (1995). Family therapy for the treatment of depressed adolescents. Psychotherapy: Theory, Research, Practice, Training, 32, 77–90.CrossRefGoogle Scholar
Dubicka, B., Hadley, S. & Roberts, C. (2006). Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. British Journal of Psychiatry, 189, 393–8.CrossRefGoogle ScholarPubMed
Duff, G. (2003a). Safety and efficacy of the SSRI class in the treatment of paediatric major depressive disorder. Expert Working Group on Safety of Medicines. Available at: http://www.mhra.gov.uk/news/2003.htm#ssri.
Duff, G. (2003b). Safety of Seroxat (paroxetine) in children and adolescents under 18 years – contraindication in the treatment of depressive illness. United Kingdom's Department of Health's Chairman of Committee of Safety of Medicine's message on paroxetine. Available at: http://www.mhra.gov.uk/news/2003.htm#june.
Duffett, R., Hill, P. & Lelliott, P. (1999). Use of electroconvulsive therapy in young people. British Journal of Psychiatry, 175, 228–30.CrossRefGoogle ScholarPubMed
Dujovne, V. F., Barnard, M. U. & Rapoff, M. A. (1995). Pharmacological and cognitive behavioral approaches in the treatment of childhood depression: a review and critique. Clinical Psychology Review, 15(7), 589–611.CrossRefGoogle Scholar
Emslie, G. J., Rush, A. J., Weinberg, W. A.et al. (1997). A double blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031–7.CrossRefGoogle ScholarPubMed
Emslie, G. J., Heiligenstein, J. H. & Wagner, K. D. (2002). Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1205–15.CrossRefGoogle ScholarPubMed
Fine, S., Forth, A., Gilbert, M. & Haley, G. (1991). Group therapy for adolescent depressive disorder: a comparison of social skills and therapeutic support. Journal of American Academy of Child and Adolescent Psychiatry, 30, 79–85.CrossRefGoogle ScholarPubMed
Fleming, J. E. & Offord, D. R. (1990). Epidemiology of childhood depressive disorders: A critical review. Journal of American Academy of Child and Adolescent Psychiatry, 29, 571–80.CrossRefGoogle ScholarPubMed
Garrison, C. Z., Addy, C. L. K., Jackson, K. L., McKeown, R. E. & Waller, J. L. (1992). Major depressive disorder and dysthymia in young adolescents. American Journal of Epidemiology, 135, 792–802.CrossRefGoogle ScholarPubMed
Gjerde, P. F. & Westenberg, P. M. (1998). Dysphoric adolescents as young adults: A prospective study of the psychological sequelae of depressed mood in adolescence. Journal of Research on Adolescence, 8(3), 377–402.CrossRefGoogle Scholar
Glod, C. A., Lynch, A., Flynn, E., Berkowitz, C. & Baldessarini, R. J. (2003). Open trial of bupropion SR in adolescent major depression. Journal of Child and Adolescent Psychiatry Nursing, 16, 123–30.CrossRefGoogle ScholarPubMed
Goodnick, P. J., Jorge, C. A., Hunter, T. & Kumar, A. M. (2000). Nefazodone treatment of adolescent depression: an open-label study of response and biochemistry. Annals of Clinical Psychiatry, 12, 97–100.CrossRefGoogle ScholarPubMed
Goodyer, I. M., Herbert, J., Tamplin, A., Secher, S. M. & Pearson, J. (1997). Short-term outcome of major depression: II. Life events, family dysfunction, and friendship difficulties as predictors of persistent disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 474–80.CrossRefGoogle ScholarPubMed
Goodyer, I. M., Herbert, J. & Tamplin, A. (2003). Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry. Psychological Medicine, 33, 601–10.CrossRefGoogle ScholarPubMed
Hammad, T. A., Laughren, T. & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332–9.CrossRefGoogle ScholarPubMed
Hammen, C. (1997). Depression. Hove, England: Psychology Press/Erlbaum.Google Scholar
Harrington, R., Kerfoot, M., Dyer, E.et al. (1998). Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 512–18.CrossRefGoogle ScholarPubMed
Jayson, D., Wood, A., Kroll, L., Fraser, J. & Harrington, R. (1998). Which depressed patients respond to cognitive-behavioral treatment? Journal of the American Academy of Child and Adolescent Psychiatry, 37, 35–9.CrossRefGoogle ScholarPubMed
Jureidini, J. N., Doecke, C. J., Mansfield, P. R., Haby, M. M., Menkes, D. B. & Tonkin, A. L. (2004). Efficacy and safety of antidepressants for children and adolescents. British Medical Journal, 328, 879–83.CrossRefGoogle ScholarPubMed
Kaizar, E. E., Greenhouse, J. B., Seltman, H. & Kelleher, K. (2006). Do antidepressants cause suicidality in children? A Bayesian meta-analysis. Clinical Trials, 3, 73–90.CrossRefGoogle ScholarPubMed
Kashani, J. H., Beck, N. C., Hoeper, E. W.et al. (1987a). Psychiatric disorders in a community sample of adolescents. American Journal of Psychiatry, 144, 584–9.Google Scholar
Kashani, J. H., Carlson, G. A., Beck, N. C.et al. (1987b). Depression, depressive symptoms, and depressed mood among a community sample of adolescents. American Journal of Psychiatry, 144, 931–4.Google Scholar
Keller, M. B., Ryan, N. D., Strober, M.et al. (2001). Efficacy of paroxetine in the treatment of adolescent major depressive disorder: A randomized, controlled trial. Journal of American Academy of Child and Adolescent Psychiatry, 40, 762–72.CrossRefGoogle ScholarPubMed
Kerfoot, M., Harrington, R., Harrington, V., Rogers, J. & Verduyn, C. (2004). A step too far? Randomized trial of cognitive-behaviour therapy delivered by social workers to depressed adolescents. European Child and Adolescent Psychiatry, 13, 92–9.CrossRefGoogle ScholarPubMed
Kroll, L., Harrington, R., Jayson, D., Fraser, J. & Gowers, S. (1996). Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1156–61.CrossRefGoogle ScholarPubMed
Lewinsohn, P. M., Clarke, G. N., Hops, H.et al. (1990). Cognitive-behavioral treatment for depressed adolescents. Behavior Therapy, 21, 385–401.CrossRefGoogle Scholar
Lewinsohn, P. M., Hops, H., Roberts, R. E., Seeley, J. R. & Andrew, J. A. (1993). Adolescent psychopathology, I: Prevalence and incidence of depression and other DSM-III-R disorders in high school students. Journal of Abnormal Psychology, 103, 133–44.CrossRefGoogle Scholar
Lewinsohn, P. M., Clarke, G. N., Seeley, J. R. & Rohde, P. (1994). Major depression in community adolescents: age at onset, episode duration, and time to recurrence. Journal of American Academy of Child and Adolescent Psychiatry, 33, 809–18.CrossRefGoogle ScholarPubMed
Lewinsohn, P. M. & Clarke, G. N. (1999). Psychosocial treatments for adolescent depression. Clinical Psychology Review, 19(3), 329–42.CrossRefGoogle ScholarPubMed
Mandoki, M. W., Tapia, M. R., Tapia, M. A., Summer, G. S. & Parker, J. L. (1997). Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacology Bulletin, 33, 149–54.Google ScholarPubMed
March, J., Silva, S., Petrycki, S.et al. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association, 292, 807–20.Google ScholarPubMed
Marcotte, D. (1997). Treating depression in adolescence: A review of the effectiveness of cognitive-behavioral treatments. Journal of Youth and Adolescence, 26(3), 273–83.CrossRefGoogle Scholar
Meltzer, H., Gatward, R., Goodman, R. & Ford, T. (2003). Mental health of children and adolescents in Great Britain. International Review of Psychiatry, 15, 185–7.CrossRefGoogle ScholarPubMed
Melvin, G. A., Tonge, B. J., King, N. J., Heyne, D., Gordon, M. S. & Klimkeit, E. D. (2006). A comparison of cognitive-behavioural therapy, sertraline, and their combination for adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1151–61.CrossRefGoogle ScholarPubMed
MHRA (2003). http://www.mhra.gov.uk/news/2003.htm#ssri, Vol. 2004, Medicines and Healthcare products Regulatory Agency.
MHRA (2004). http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/safetymessages/ssrioverview_101203.htm, Vol. 2004, Medicines and Healthcare products Regulatory Agency.
Milin, R. P., Simeon, J. & Spenst, W. P. (1999). Poster presented at the 46th Annual American Academy of Child and Adolescent Psychiatry Meeting, Chicago, IL. October 19–21. [abstract] NR67: 104–5.
Mufson, L. & Fairbanks, J. (1996). Interpersonal psychotherapy for depressed adolescents: a one year naturalistic follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1145–55.CrossRefGoogle ScholarPubMed
Mufson, L., Moreau, D., Weissman, M. M., Wickmaranted, P., Martin, J. & Samoilov, A. (1994). Modification of interpersonal psychotherapy with depressed adolescents (IPT-A): Phase I and II studies. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 695–705.CrossRefGoogle ScholarPubMed
Mufson, L., Weissman, M. M., Moreau, D. & Garfinkel, R. (1999). Efficacy of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 56, 573–9.CrossRefGoogle ScholarPubMed
Mufson, L., Dorta, K. P., Wickramarante, P., Nomura, Y., Olfson, M. & Weissman, M. (2004). A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 61, 577–84.CrossRefGoogle ScholarPubMed
National Institute for Health and Clinical Excellence. (2005). CG28 Depression in children and young people: Full guideline. http://www.nice.org.uk/pdf/cg028fullguideline.pdf.
Reinecke, M. A., Ryan, N. E. & DuBois, D. L. (1998). Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: A review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 26–34.CrossRefGoogle ScholarPubMed
Rosselló, J. & Bernal, G. (1999). The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. Journal of Consulting & Clinical Psychology, 67(5), 734–45.CrossRefGoogle ScholarPubMed
Rudnick, A. (2001). Ethics of ECT for children (Letters to the Editor). Journal of the American Academy of Child and Adolescent Psychiatry, 40(4), 387.CrossRefGoogle Scholar
Simon, G. E., Savarino, J., Opereskalski, B. & Wang, P. S. (2006). Suicide risk during antidepressant treatment. American Journal of Psychiatry, 163, 41–7.CrossRefGoogle ScholarPubMed
Strober, M., Pataki, C. & DeAntonio, M. (1998). Complete remission of ‘treatment resistant’ severe melancholia in adolescents with phenelzine: two case reports. Journal of Affective Disorders, 50, 55–8.CrossRefGoogle ScholarPubMed
US Food and Drug Administration (2003). FDA statement regarding the anti-depressant Paxil for pediatric population. FDA Talking Paper, June 19. Available at: http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01230.html.
US Food and Drug Administration (2004). Suicidality in children and adolescents being treated with antidepressant medications. FDA Public Health Advisory, October 15. Available at: www.fda.gov/cder/drug/antidepressants/SSRIPHA200410.htm.
Wagner, K. D., Ambrosini, P., Rynn, M.et al. (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. Journal of the American Medical Association, 290, 1033–41.CrossRefGoogle ScholarPubMed
Wagner, K. D., Robb, A. S., Findling, R. L., Jin, J., Gutierrez, M. M. & Heydorn, W. E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161(6), 1079–83.CrossRefGoogle ScholarPubMed
Walter, G., Koster, K. & Rey, J. M. (1999a). Electroconvulsive therapy in adolescents: experience, knowledge, and attitudes of recipients. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 594–9.CrossRefGoogle Scholar
Walter, G., Rey, J. M. & Mitchell, P. B. (1999b). Practitioner review: electroconvulsive therapy in adolescents. Journal of Child Psychology and Psychiatry, 40, 325–34.CrossRefGoogle Scholar
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. The Lancet, 363, 1341–5.CrossRefGoogle ScholarPubMed
Wood, A., Harrington, R. & Moore, A. (1996). Controlled trial of a brief cognitive-behavioral intervention in adolescent patients with depressive disorders. Journal of Child Psychology and Psychiatry and Allied Disciplines, 37, 737–46.CrossRefGoogle Scholar
Zito, J. M., Safer, D. J., DosReis, S.et al. (2002). Rising prevalence of antidepressant treatment for US children and adolescents. Pediatrics, 109, 721–7.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×